Toxoplasmosis in Pregnancy: a Neglected Bane but a Serious Threat in Nigeria

Overview

Journal Parasitology

Specialty Parasitology

Date 2019 Nov 7

PMID 31690354

Citations 3

Authors

Oyetunde T Oyeyemi

Ifeoluwa T Oyeyemi

Isaac A Adesina

Adebisi M Tiamiyu

Yinka D Oluwafemi

Roseangela I Nwuba

Rafaella F Q Grenfell

Affiliations

Soon will be listed here.

Abstract

Toxoplasmosis is a global health threat in which occurrence in pregnant women poses grave consequences to fetal wellbeing. Studies on prenatal Toxoplasma gondii infection are generally limited in sub-Saharan African countries, including Nigeria. The risk of transmission of toxoplasmosis is very high in Nigeria due to the favourable climatic conditions and prevailing behavioural and socio-economic factors that could aid transmission. Currently, there are no systematic and organized procedures for diagnosis and treatment of maternal toxoplasmosis in Nigeria. These conditions forecast possible unabated transmission in many areas and exponential impact on associated adverse events of the disease during pregnancy. This paper highlights the importance of early diagnosis and treatment during pregnancy which may forestall subsequent development of infection in children delivered by infected mothers. Inclusion of toxoplasmosis control policy in the routine antenatal care of pregnant women is therefore strongly recommended.

Citing Articles

Unilateral visual impairment and blindness in school children - prevalence and aetiology in Saki-East LGA of Oyo State, Nigeria.

Ibukun F, Ugalahi M, Bekibele C Eye (Lond). 2024; 38(11):2117-2123.

PMID: 38448733 PMC: 11269637. DOI: 10.1038/s41433-024-02960-2.

Seroprevalence, Risk Factors and Maternal-Fetal Outcomes of in Pregnant Women from WHO Eastern Mediterranean Region: Systematic Review and Meta-Analysis.

Rabaan A, Uzairue L, Alfaraj A, A Halwani M, Muzaheed , Alawfi A Pathogens. 2023; 12(9).

PMID: 37764965 PMC: 10537388. DOI: 10.3390/pathogens12091157.

Human toxoplasmosis in Mozambique: gaps in knowledge and research opportunities.

Manuel L, Santos-Gomes G, Noormahomed E Parasit Vectors. 2020; 13(1):571.

PMID: 33176884 PMC: 7659051. DOI: 10.1186/s13071-020-04441-3.

References

Torgerson P, Mastroiacovo P . The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013; 91(7):501-8. PMC: 3699792. DOI: 10.2471/BLT.12.111732. View

Doudou Y, Renaud P, Coralie L, Jacqueline F, Hypolite S, Hypolite M . Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo. Asian Pac J Trop Biomed. 2013; 4(1):69-74. PMC: 3819499. DOI: 10.1016/S2221-1691(14)60211-2. View

Andrade G, Vasconcelos-Santos D, Carellos E, Romanelli R, Vitor R, Carneiro A . Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy. J Pediatr (Rio J). 2009; 86(1):85-8. DOI: 10.2223/JPED.1948. View

HUTCHISON W, Dunachie J, SIIM J, Work K . Life cycle of toxoplasma gondii. Br Med J. 1969; 4(5686):806. PMC: 1630290. DOI: 10.1136/bmj.4.5686.806-b. View

Awobode H, Olubi I . Prevalence of Toxoplasma gondii and HIV infection among pregnant women in Ibadan North Local Government, Oyo State. Afr J Med Med Sci. 2016; 43 Suppl:39-45. View

Juliano P, Blotta M, Altemani A . ICAM-1 is overexpressed by villous trophoblasts in placentitis. Placenta. 2005; 27(6-7):750-7. DOI: 10.1016/j.placenta.2005.07.008. View

Millar P, Moura F, Bastos O, Mattos D, Fonseca A, Sudre A . Toxoplasmosis-related knowledge among pregnant and postpartum women attended in public health units in Niterói, Rio De Janeiro, Brazil. Rev Inst Med Trop Sao Paulo. 2014; 56(5):433-8. PMC: 4172116. DOI: 10.1590/s0036-46652014000500011. View

Flegr J, Prandota J, Sovickova M, Israili Z . Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014; 9(3):e90203. PMC: 3963851. DOI: 10.1371/journal.pone.0090203. View

Barragan A, Brossier F, Sibley L . Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2. Cell Microbiol. 2005; 7(4):561-8. DOI: 10.1111/j.1462-5822.2005.00486.x. View

10.

Hung C, Fan C, Su K, Sung F, Chiou H, Gil V . Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of Sao Tome and Principe. Trans R Soc Trop Med Hyg. 2006; 101(2):134-9. DOI: 10.1016/j.trstmh.2006.04.012. View

11.

Halonen S, Weiss L . Toxoplasmosis. Handb Clin Neurol. 2013; 114:125-45. PMC: 4157368. DOI: 10.1016/B978-0-444-53490-3.00008-X. View

12.

Tenter A, Heckeroth A, Weiss L . Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13):1217-58. PMC: 3109627. DOI: 10.1016/s0020-7519(00)00124-7. View

13.

Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Bonithon Kopp C . Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013; 56(9):1223-31. DOI: 10.1093/cid/cit032. View

14.

Lin Y, Liao Y, Liao L, Chen F, Kuo H, He S . Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol Res. 2008; 103(1):67-74. DOI: 10.1007/s00436-008-0928-1. View

15.

Robbins J, Zeldovich V, Poukchanski A, Boothroyd J, Bakardjiev A . Tissue barriers of the human placenta to infection with Toxoplasma gondii. Infect Immun. 2011; 80(1):418-28. PMC: 3255695. DOI: 10.1128/IAI.05899-11. View

16.

Capretti M, De Angelis M, Tridapalli E, Orlandi A, Marangoni A, Moroni A . Toxoplasmosis in pregnancy in an area with low seroprevalence: is prenatal screening still worthwhile?. Pediatr Infect Dis J. 2013; 33(1):5-10. DOI: 10.1097/INF.0000000000000006. View

17.

Akinbami A, Adewunmi A, Rabiu K, Wright K, Dosunmu A, Dada M . Seroprevalence of Toxoplasma gondii antibodies amongst pregnant women at the Lagos State University Teaching Hospital, Nigeria. Niger Postgrad Med J. 2010; 17(2):164-7. View

18.

Rouatbi M, Amairia S, Amdouni Y, Boussaadoun M, Ayadi O, Al-Hosary A . Toxoplasma gondii infection and toxoplasmosis in North Africa: a review. Parasite. 2019; 26:6. PMC: 6376878. DOI: 10.1051/parasite/2019006. View

19.

Gelaye W, Kebede T, Hailu A . High prevalence of anti-toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two Hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015; 34:41-5. DOI: 10.1016/j.ijid.2015.03.005. View

20.

Ndiaye D, Ndiaye A, Sene P, NDiaye J, Faye B, Ndir O . [Evaluation of serological tests of toxoplasmosis in pregnant women realized at the Laboratory of Parasitology and Mycology of Le Dantec Teaching Hospital in 2002]. Dakar Med. 2008; 52(1):58-61. View